Hybrid immunity from SARS-CoV-2 infection and mRNA BNT162b2 vaccine among Thai school-aged children-Reference-Cited by-同舟云学术

Hybrid immunity from SARS-CoV-2 infection and mRNA BNT162b2 vaccine among Thai school-aged children

Published:2023-12 Issue: Volume:15 Page:100414
ISSN:2590-1362
Container-title:Vaccine: X
language:en
Short-container-title:Vaccine: X

Author:

Saraban Kanchanok^ORCID,Suntarattiwong Piyarat,Chantasrisawad Napaporn^ORCID,Boonsathorn Sophida^ORCID,Kosalaraksa Pope,Phongsamart Wanatpreeya,Tangsathapornpong Auchara,Jaruampornpan Peera^ORCID,Srisarang Suchada,Puthanakit Thanyawee

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference33 articles.

1. World Health Organization. WHO Coronavirus (COVID-19) Dashboard; 2021. https://covid19.who.int/table [accessed 06 November 2021].

2. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data;Haas;Lancet,2021

3. Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age;Walter;N Engl J Med,2022

4. Effectiveness of BNT162b2 Vaccine against Omicron in Children 5 to 11 Years of Age;Tan;N Engl J Med,2022

5. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression;Feikin;Lancet,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pediatric antibody responses to SARS-CoV-2 after infection and vaccination in Calgary, Canada;BMC Infectious Diseases;2024-07-18